Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018038168) HEMAGGLUTININ-BINDING PEPTIDE AND PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION WHICH CONTAINS SAME
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/038168 International Application No.: PCT/JP2017/030158
Publication Date: 01.03.2018 International Filing Date: 23.08.2017
IPC:
C07K 7/00 (2006.01) ,A61K 38/00 (2006.01) ,A61K 47/42 (2017.01) ,A61K 47/50 (2017.01) ,A61P 31/16 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
42
Proteins; Polypeptides; Degradation products thereof; Derivatives thereof
[IPC code unknown for A61K 47/50]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
14
for RNA viruses
16
for influenza or rhinoviruses
Applicants:
学校法人同志社 THE DOSHISHA [JP/JP]; 京都府京都市上京区今出川通烏丸東入玄武町601番地 601, Gembu-cho, Karasuma-Higashi-iru, Imadegawa-dori, Kamigyo-ku, Kyoto-shi, Kyoto 6028580, JP
Inventors:
西川 喜代孝 NISHIKAWA Kiyotaka; JP
高橋 美帆 TAKAHASHI Miho; JP
近江 純平 OHMI Junpei; JP
山下 誠 YAMASHITA Makoto; JP
本郷 桂 HONGO Katsura; JP
名取 泰博 NATORI Yasuhiro; JP
チンイ ツェン CHING-YI Tseng; TW
Agent:
西澤 利夫 NISHIZAWA Toshio; JP
Priority Data:
2016-16497125.08.2016JP
Title (EN) HEMAGGLUTININ-BINDING PEPTIDE AND PROPHYLACTIC/THERAPEUTIC AGENT FOR INFLUENZA VIRUS INFECTION WHICH CONTAINS SAME
(FR) PEPTIDE DE LIAISON À L'HÉMAGGLUTININE ET AGENT PROPHYLACTIQUE/THÉRAPEUTIQUE POUR UNE INFECTION PAR LE VIRUS DE LA GRIPPE QUI CONTIENT CELUI-CI
(JA) ヘマグルチニン結合ペプチド、および、これを含むインフルエンザウイルス感染症の予防・治療薬
Abstract:
(EN) A hemagglutinin-binding peptide is a tetravalent peptide, in which a peptide motif represented by SEQ ID NO: 1 is bound, directly or with a spacer interposed therebetween, to each of four amino groups located at terminals of a molecule core structure formed by binding three lysine (Lys) residues to one another.
(FR) L'invention concerne un peptide de liaison à l'hémagglutinine qui est un peptide tétravalent, dans lequel un motif peptidique représenté par SEQ ID NO : 1 est lié, directement ou avec un espaceur interposé entre eux, à chacun de quatre groupes amino situés aux bornes d'une structure de cœur de molécule formée par liaison de trois résidus de lysine (Lys) les uns aux autres.
(JA) ヘマグルチニン結合ペプチドは、3つのリジン(Lys)が結合して形成された分子核構造の端部に位置する4つのアミノ基の各々に、配列番号1のペプチドモチーフ が、直接またはスペーサーを介して結合している4価ペプチドである。
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)